Cargando…
Adenosine A(3) receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury
BACKGROUND: Traumatic brain injury (TBI) is a common pathological condition that presently lacks a specific pharmacological treatment. Adenosine levels rise following TBI, which is thought to be neuroprotective against secondary brain injury. Evidence from stroke and inflammatory disease models sugg...
Autores principales: | Farr, Susan A., Cuzzocrea, Salvatore, Esposito, Emanuela, Campolo, Michela, Niehoff, Michael L., Doyle, Timothy M., Salvemini, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659122/ https://www.ncbi.nlm.nih.gov/pubmed/33183330 http://dx.doi.org/10.1186/s12974-020-02009-7 |
Ejemplares similares
-
Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment
por: Squillace, Silvia, et al.
Publicado: (2022) -
Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in Mice
por: Ahmad, Akbar, et al.
Publicado: (2013) -
FeTPPS Reduces Secondary Damage and Improves Neurobehavioral Functions after Traumatic Brain Injury
por: Bruschetta, Giuseppe, et al.
Publicado: (2017) -
Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in Mice
por: Impellizzeri, Daniela, et al.
Publicado: (2016) -
Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion
por: Ardizzone, Alessio, et al.
Publicado: (2022)